Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director Quarterly results
|
Axogen, Inc. (AXGN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/04/2021 |
GN
| Axogen, Inc. to Participate at Upcoming February Investor Conferences |
02/01/2021 |
GN
| Axogen, Inc. to Report Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call on February 22, 2021 |
01/11/2021 |
GN
| Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2020 |
01/05/2021 |
GN
| Axogen to Participate at AAHS ASPN ASRM 2021 Virtual Annual Meetings |
12/23/2020 |
GN
| Axogen Sponsors Donate Life at 2021 Virtual Rose Parade Celebration |
10/08/2020 |
GN
| Axogen, Inc. to Report Third Quarter 2020 Financial Results and Host Conference Call on October 29, 2020 |
09/30/2020 |
GN
| Axogen, Inc. Appoints Paul G. Thomas to Board of Directors |
09/25/2020 |
GN
| Axogen, Inc. to Present at the JMP Securities MedTech Bio Summit |
08/31/2020 |
GN
| Axogen, Inc. to Present at the Cantor Virtual Global Healthcare Conference |
07/15/2020 |
GN
| Axogen, Inc. to Report Second Quarter 2020 Financial Results and Host Conference Call on August 5, 2020 |
07/01/2020 |
GN
| Axogen Announces New Seven-Year Financing Agreement with Oberland Capital and Provides Preliminary Second Quarter Revenue Estimate |
06/01/2020 |
GN
| Axogen, Inc. Announces Planned Retirement of Greg Freitag and Appoints Brad Ottinger as General Counsel and Chief Compliance Officer |
05/20/2020 |
GN
| Axogen, Inc. to Present at the Jefferies Virtual Healthcare Conference |
04/15/2020 |
GN
| Axogen, Inc. to Report First Quarter 2020 Financial Results and Host Conference Call on May 6, 2020 |
01/13/2020 |
GN
| Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance |
01/08/2020 |
GN
| Axogen Sponsored RANGER® Registry Reaches 2,000 Nerve Repair Enrollment Milestone |
01/02/2020 |
GN
| Axogen to Participate at AAHS ASPN ASRM 2020 Annual Meetings |
01/02/2020 |
GN
| Axogen, Inc. to Participate at JP Morgan 38th Annual Healthcare Conference |
12/18/2019 |
GN
| Axogen awarded research grant from the Advanced Regenerative Manufacturing Institute |
12/04/2019 |
GN
| Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float |
11/21/2019 |
GN
| Axogen, Inc. to Participate at Piper Jaffray 31st Annual Healthcare Conference |
11/11/2019 |
GN
| Axogen, Inc. to Participate at Jefferies London Healthcare Conference |
10/23/2019 |
GN
| Axogen, Inc. to Report Third Quarter 2019 Financial Results and Host Conference Call on November 6, 2019 |
09/19/2019 |
GN
| Axogen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference |
09/11/2019 |
GN
| Bragar Eagel & Squire is Investigating Certain Officers and Directors of Mammoth Energy, Acer Therapeutics, Realogy Holdings, and AxoGen and Encourages Investors to Contact the Firm |
08/27/2019 |
GN
| Axogen to Participate in the 74th Annual American Society for Surgery of the Hand Meeting |
08/14/2019 |
GN
| Bragar Eagel & Squire is Investigating Certain Officers and Directors of Lannett, Molson Coors, AxoGen, and American Renal Associates and Encourages Investors to Contact the Firm |
07/29/2019 |
GN
| Axogen, Inc. to Participate at Canaccord Genuity 39th Annual Growth Conference |
07/26/2019 |
GN
| Axogen Announces Publication of the 100th Peer-Reviewed Clinical Paper Featuring its Product Portfolio for Peripheral Nerve Repair |
07/22/2019 |
GN
| Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of AxoGen (NASDAQ: AXGN) and Encourages AxoGen Investors to Contact the Firm |
07/19/2019 |
GN
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of AxoGen, Inc. - AXGN |
05/23/2019 |
GN
| Axogen, Inc. to Participate at Upcoming Investor Conferences |
05/02/2019 |
GN
| Axogen, Inc. Appoints New Members to Board of Directors |
04/22/2019 |
GN
| Axogen, Inc. Announces Completion of Planned Interim Analysis and One-Time Enrollment Expansion for RECON® Study |
|
|
|